Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study.

Raj V, Liang HC, Woodward ND, Bauernfeind AL, Lee J, Dietrich MS, Park S, Cowan RL.

J Psychopharmacol. 2010 Feb;24(2):187-201. doi: 10.1177/0269881109103203. Epub 2009 Mar 20.

2.

Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.

Watkins TJ, Raj V, Lee J, Dietrich MS, Cao A, Blackford JU, Salomon RM, Park S, Benningfield MM, Di Iorio CR, Cowan RL.

Psychopharmacology (Berl). 2013 May;227(1):41-54. doi: 10.1007/s00213-012-2936-1. Epub 2012 Dec 16.

3.
4.

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.

Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.

J Psychopharmacol. 2006 Mar;20(2):211-25. Review.

PMID:
16510479
5.

Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study.

Cowan RL, Lyoo IK, Sung SM, Ahn KH, Kim MJ, Hwang J, Haga E, Vimal RL, Lukas SE, Renshaw PF.

Drug Alcohol Depend. 2003 Dec 11;72(3):225-35.

PMID:
14643939
6.

Involvement of inferior parietal lobules in prospective memory impairment during acute MDMA (ecstasy) intoxication: an event-related fMRI study.

Ramaekers JG, Kuypers KP, Wingen M, Heinecke A, Formisano E.

Neuropsychopharmacology. 2009 Jun;34(7):1641-8. doi: 10.1038/npp.2008.219. Epub 2008 Dec 17. Erratum in: Neuropsychopharmacology. 2009 Jun;34(7):1883-4.

7.

Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users.

Daumann J, Schnitker R, Weidemann J, Schnell K, Thron A, Gouzoulis-Mayfrank E.

Neuroreport. 2003 Oct 27;14(15):1983-7.

PMID:
14561934
8.

Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.

Quednow BB, Jessen F, Kuhn KU, Maier W, Daum I, Wagner M.

J Psychopharmacol. 2006 May;20(3):373-84.

PMID:
16574711
9.

MDMA intoxication and verbal memory performance: a placebo-controlled pharmaco-MRI study.

Kuypers KP, Wingen M, Heinecke A, Formisano E, Ramaekers JG.

J Psychopharmacol. 2011 Aug;25(8):1053-61. doi: 10.1177/0269881111405361. Epub 2011 May 26.

PMID:
21616977
10.

Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).

Taurah L, Chandler C, Sanders G.

Psychopharmacology (Berl). 2014 Feb;231(4):737-51. doi: 10.1007/s00213-013-3288-1. Epub 2013 Oct 11.

PMID:
24114426
11.

Prefrontal N-acetylaspartate is strongly associated with memory performance in (abstinent) ecstasy users: preliminary report.

Reneman L, Majoie CB, Schmand B, van den Brink W, den Heeten GJ.

Biol Psychiatry. 2001 Oct 1;50(7):550-4.

PMID:
11600108
12.

Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.

Indlekofer F, Piechatzek M, Daamen M, Glasmacher C, Lieb R, Pfister H, Tucha O, Lange KW, Wittchen HU, Sch├╝tz CG.

J Psychopharmacol. 2009 Jul;23(5):495-509. doi: 10.1177/0269881108091076. Epub 2008 Jul 17.

PMID:
18635709
13.

Human Ecstasy use is associated with increased cortical excitability: an fMRI study.

Bauernfeind AL, Dietrich MS, Blackford JU, Charboneau EJ, Lillevig JG, Cannistraci CJ, Woodward ND, Cao A, Watkins T, Di Iorio CR, Cascio C, Salomon RM, Cowan RL.

Neuropsychopharmacology. 2011 May;36(6):1127-41. doi: 10.1038/npp.2010.244. Epub 2011 Feb 16.

14.

Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine ("Ecstasy")/polydrug users.

Burgess AP, Venables L, Jones H, Edwards R, Parrott AC.

Psychopharmacology (Berl). 2011 Aug;216(4):545-56. doi: 10.1007/s00213-011-2249-9. Epub 2011 Mar 10.

PMID:
21390504
15.

Memory performance in abstinent 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users.

Groth-Marnat G, Howchar H, Marsh A.

Percept Mot Skills. 2007 Feb;104(1):43-55.

PMID:
17450963
17.

Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.

Bedi G, Van Dam NT, Redman J.

J Psychopharmacol. 2010 Feb;24(2):233-40. doi: 10.1177/0269881108097631. Epub 2008 Oct 2.

PMID:
18832429
18.

Prior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study.

Karageorgiou J, Dietrich MS, Charboneau EJ, Woodward ND, Blackford JU, Salomon RM, Cowan RL.

Neuroimage. 2009 Jul 1;46(3):817-26. doi: 10.1016/j.neuroimage.2009.02.029. Epub 2009 Mar 2.

19.

Memory impairment in abstinent MDMA ("Ecstasy") users.

Bolla KI, McCann UD, Ricaurte GA.

Neurology. 1998 Dec;51(6):1532-7.

PMID:
9855498
20.

The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.

Gouzoulis-Mayfrank E, Daumann J.

J Psychopharmacol. 2006 Mar;20(2):188-93. Review.

PMID:
16510477

Supplemental Content

Support Center